Medicare drug costs should parallel those of Medicaid

Genevieve RegalGail BloomIn the United States, the uncontrolled escalation of Medicare Part D prescription drug costs is a national problem. Experts predict that this price growth will continue. This presents a challenge for Medicare beneficiaries on fixed incomes.
In 2029, the total number of Americans eligible for Medicare will rise to 71 million, a surge that will push Medicare …
(continue reading)

Article source: